Coronary Artery Bypass Surgery in Diffuse Advanced Coronary Artery Disease: 1-Year Clinical and Angiographic Results
27 September 2016
18 February 2017
29 March 2017 (eFirst)
Background Proper treatment of patients with diffuse, severe coronary artery disease (CAD) is a challenge due to its complexity. Thus, data on the outcomes after coronary artery bypass graft (CABG) in this population is scarce. In this study, we aimed to determine the impact of CABG on the clinical and functional status, as well as graft patency in those individuals.
Methods Patients with severe and diffuse CAD who underwent incomplete CABG due to complex anatomy or extensive distal coronary involvement were evaluated preoperatively and 1 year after surgery. Postoperative coronary angiography was performed to evaluate graft patency. Graft occlusion was defined as the complete absence of opacification of the target vessel. Stratified analysis of graft occlusion was performed by graft type and territories, defined as left anterior descending artery (LAD), the left circumflex branch, and the right coronary artery territories; the latter two, grouped, were further classified as non-LAD territory.
Results A total of 57 patients were included, in whom 131 grafts were placed. There was a significant improvement in Canadian Cardiovascular Society angina symptom severity (Z = –6.1; p < 0.001) and maximum oxygen uptake (p < 0.001), with a corresponding decrease in the use of long-acting nitrates (p < 0.001). The overall graft occlusion rate was 19.1%, with no significant difference between LAD and non-LAD territories (p = 0.08). However, a significantly lower occlusion rate was noted for the internal mammary artery (IMA) grafts when compared with saphenous vein grafts (p = 0.01), though this difference was only significant in the LAD territory (p = 0.04). Overall, the use of venous graft was the only predictor occlusion at 1 year (odds ratio: 4.03; p = 0.016).
Conclusion In patients with diffuse CAD, incomplete CABG surgery resulted in a significant clinical improvement, with acceptable graft occlusion rates at 1 year, particularly for IMA grafts to the LAD territory.
- 1 McNeil M, Buth K, Brydie A, MacLaren A, Baskett R. The impact of diffuseness of coronary artery disease on the outcomes of patients undergoing primary and reoperative coronary artery bypass grafting. Eur J Cardiothorac Surg 2007; 31 (5) 827-833
- 2 Rocha AS, Dassa NP, Pittella FJ , et al. High mortality associated with precluded coronary artery bypass surgery caused by severe distal coronary artery disease. Circulation 2005; 112 (9, Suppl): I328-I331
- 3 Goldman S, Zadina K, Moritz T , et al; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004; 44 (11) 2149-2156
- 4 Graham MM, Chambers RJ, Davies RF. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. J Thorac Cardiovasc Surg 1999; 118 (4) 618-627
- 5 Jalal A. An objective method for grading of distal disease in the grafted coronary arteries. Interact Cardiovasc Thorac Surg 2007; 6 (4) 451-455
- 6 Tatoulis J. Total arterial coronary revascularization-patient selection, stenoses, conduits, targets. Ann Cardiothorac Surg 2013; 2 (4) 499-506
- 7 Tura BR, Martino HF, Gowdak LH , et al. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials 2007; 8: 2
- 8 Campeau L. Letter: Grading of angina pectoris. Circulation 1976; 54 (3) 522-523
- 9 Keteyian SJ, Brawner CA, Savage PD , et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J 2008; 156 (2) 292-300
- 10 Kolh P, Windecker S. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J 2014; 35 (46) 3235-3236
- 11 Morrow DA, Boden WE. Stable ischemic heart disease. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Saunders; 2012: 1210-1269
- 12 Pereg D, Fefer P, Samuel M , et al. Native coronary artery patency after coronary artery bypass surgery. JACC Cardiovasc Interv 2014; 7 (7) 761-767
- 13 Bittencourt MS, Hulten E. Protected coronary arteries: do open grafts pave the way to survival?. JACC Cardiovasc Imaging 2014; 7 (6) 590-592
- 14 Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg 2013; 257 (5) 824-833
- 15 Collins P, Webb CM, Chong CF, Moat NE ; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation 2008; 117 (22) 2859-2864
- 16 Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 1994; 81 (9) 1254-1269
- 17 Muzaffar S, Shukla N, Angelini GD, Jeremy JY. Acute hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase in the porcine pulmonary artery. Thorax 2005; 60 (4) 305-313